Genome-Wide Mapping of Bivalent Histone Modifications in Hepatic Stem/Progenitor Cells

por Kanayama, Kengo, Chiba, Tetsuhiro, Oshima, Motohiko, Kanzaki, Hiroaki, Koide, Shuhei, Saraya, Atsunori, Miyagi, Satoru, Mimura, Naoya, Kusakabe, Yuko, Saito, Tomoko, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Maruyama, Hitoshi, Iwama, Atsushi, Kato, Naoya
Publicado 2019

The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells

por Kanzaki, Hiroaki, Chiba, Tetsuhiro, Kaneko, Tatsuya, Ao, Junjie, Kan, Motoyasu, Muroyama, Ryosuke, Nakamoto, Shingo, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Zen, Yoh, Kotani, Ai, Sekiba, Kazuma, Otsuka, Motoyuki, Ohtsuka, Masayuki, Kato, Naoya
Publicado 2022

Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma

por Kondo, Takayuki, Koroki, Keisuke, Kanzaki, Hiroaki, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Ogasawara, Sadahisa, Ooka, Yoshihiko, Nakamoto, Shingo, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Kuboki, Satoshi, Ohtsuka, Masayuki, Kato, Naoya
Publicado 2022

Switching to systemic therapy after locoregional treatment failure: Definition and best timing

por Ogasawara, Sadahisa, Ooka, Yoshihiko, Koroki, Keisuke, Maruta, Susumu, Kanzaki, Hiroaki, Kanayama, Kengo, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Suzuki, Eiichiro, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Kato, Naoya
Publicado 2020

Long-term administration of Tolvaptan to patients with decompensated cirrhosis

por Kanayama, Kengo, Chiba, Tetsuhiro, Kobayashi, Kazufumi, Koroki, Keisuke, Maruta, Susumu, Kanzaki, Hiroaki, Kusakabe, Yuko, Saito, Tomoko, Kiyono, Soichiro, Nakamura, Masato, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Yasui, Shin, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Kato, Naoya
Publicado 2020

Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients

por Kondo, Takayuki, Fujiwara, Kisako, Nakagawa, Miyuki, Fujimoto, Kentaro, Yumita, Sae, Ishino, Takamasa, Ogawa, Keita, Iwanaga, Terunao, Koroki, Keisuke, Kanzaki, Hiroaki, Inoue, Masanori, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Ogasawara, Sadahisa, Nakamoto, Shingo, Chiba, Tetsuhiro, Kato, Jun, Kato, Naoya
Publicado 2023

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

por Maeda, Takahiro, Kanzaki, Hiroaki, Chiba, Tetsuhiro, Ao, Junjie, Kanayama, Kengo, Maruta, Susumu, Kusakabe, Yuko, Saito, Tomoko, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Nakagawa, Ryo, Muroyama, Ryosuke, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya
Publicado 2019

Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury

por Kondo, Takayuki, Fujimoto, Kentaro, Fujiwara, Kisako, Yumita, Sae, Ishino, Takamasa, Ogawa, Keita, Nakagawa, Miyuki, Iwanaga, Terunao, Koroki, Keisuke, Kanzaki, Hiroaki, Inoue, Masanori, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Ogasawara, Sadahisa, Nakamoto, Shingo, Chiba, Tetsuhiro, Kato, Jun, Fujiwara, Keiichi, Kato, Naoya
Publicado 2023

Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer

por Imai, Yushi, Chiba, Tetsuhiro, Kondo, Takayuki, Kanzaki, Hiroaki, Kanayama, Kengo, Ao, Junjie, Kojima, Ryuta, Kusakabe, Yuko, Nakamura, Masato, Saito, Tomoko, Nakagawa, Ryo, Suzuki, Eiichiro, Nakamoto, Shingo, Muroyama, Ryosuke, Tawada, Akinobu, Matsumura, Tomoaki, Nakagawa, Tomoo, Kato, Jun, Kotani, Ai, Matsubara, Hisahiro, Kato, Naoya
Publicado 2020

The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma

por Kondo, Takayuki, Fujiwara, Kisako, Nakagawa, Miyuki, Unozawa, Hidemi, Iwanaga, Terunao, Sakuma, Takafumi, Fujita, Naoto, Koroki, Keisuke, Kanzaki, Hiroaki, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Kato, Naoya
Publicado 2022

Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus

por Ma, Yaojia, Nakamoto, Shingo, Ao, Junjie, Qiang, Na, Kogure, Tadayoshi, Ogawa, Keita, Nakagawa, Miyuki, Fujiwara, Kisako, Iwanaga, Terunao, Kojima, Ryuta, Kanzaki, Hiroaki, Koroki, Keisuke, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Nakagawa, Ryo, Ogasawara, Sadahisa, Muroyama, Ryosuke, Chiba, Tetsuhiro, Kato, Jun, Kato, Naoya
Publicado 2022

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma

por Ao, Junjie, Chiba, Tetsuhiro, Kanzaki, Hiroaki, Kanayama, Kengo, Shibata, Shuhei, Kurosugi, Akane, Iwanaga, Terunao, Kan, Motoyasu, Sakuma, Takafumi, Qiang, Na, Ma, Yaojia, Kojima, Ryuta, Kusakabe, Yuko, Nakamura, Masato, Kobayashi, Kazufumi, Kiyono, Soichiro, Kanogawa, Naoya, Saito, Tomoko, Nakagawa, Ryo, Kondo, Takayuki, Ogasawara, Sadahisa, Suzuki, Eiichiro, Nakamoto, Shingo, Muroyama, Ryosuke, Tawada, Akinobu, Kato, Jun, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya
Publicado 2021

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma

por Kanzaki, Hiroaki, Chiba, Tetsuhiro, Ao, Junjie, Koroki, Keisuke, Kanayama, Kengo, Maruta, Susumu, Maeda, Takahiro, Kusakabe, Yuko, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Muroyama, Ryosuke, Nakamoto, Shingo, Yasui, Shin, Tawada, Akinobu, Arai, Makoto, Kanda, Tatsuo, Maruyama, Hitoshi, Mimura, Naoya, Kato, Jun, Zen, Yoh, Ohtsuka, Masayuki, Iwama, Atsushi, Kato, Naoya
Publicado 2021

Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial

por Ogasawara, Sadahisa, Koroki, Keisuke, Makishima, Hirokazu, Wakatsuki, Masaru, Takahashi, Asahi, Yumita, Sae, Nakagawa, Miyuki, Ishino, Takamasa, Ogawa, Keita, Fujiwara, Kisako, Iwanaga, Terunao, Sakuma, Takafumi, Fujita, Naoto, Kojima, Ryuta, Kanzaki, Hiroaki, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Nakagawa, Ryo, Nakamoto, Shingo, Muroyama, Ryosuke, Chiba, Tetsuhiro, Ozawa, Yoshihito, Kawasaki, Yohei, Kurokawa, Tomoya, Hanaoka, Hideki, Tsuji, Hiroshi, Kato, Naoya
Publicado 2022

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

por Kanogawa, Naoya, Ogasawara, Sadahisa, Maruta, Susumu, Iino, Yotaro, Obu, Masamichi, Ishino, Takamasa, Ogawa, Keita, Yumita, Sae, Iwanaga, Terunao, Unozawa, Hidemi, Nakagawa, Miyuki, Fujiwara, Kisako, Sakuma, Takafumi, Fujita, Naoto, Kojima, Ryuta, Kanzaki, Hiroaki, Koroki, Keisuke, Kobayashi, Kazufumi, Inoue, Masanori, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Nakamoto, Shingo, Muroyama, Ryosuke, Chiba, Tetsuhiro, Itobayashi, Ei, Koma, Yoshihiro, Azemoto, Ryosaku, Kato, Jun, Kato, Naoya
Publicado 2023

Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma

por Kanogawa, Naoya, Ogasawara, Sadahisa, Ooka, Yoshihiko, Inoue, Masanori, Wakamatsu, Toru, Yokoyama, Masayuki, Maruta, Susumu, Unozawa, Hidemi, Iwanaga, Terunao, Sakuma, Takafumi, Fujita, Naoto, Koroki, Keisuke, Kanzaki, Hiroaki, Maeda, Takahiro, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Motoyama, Tenyu, Suzuki, Eiichiro, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Takemura, Ryo, Nozaki‐Taguchi, Natsuko, Shiroh, Isono, Yokosuka, Osamu, Kato, Naoya
Publicado 2020

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma

por Kusakabe, Yuko, Chiba, Tetsuhiro, Oshima, Motohiko, Koide, Shuhei, Rizq, Ola, Aoyama, Kazumasa, Ao, Junjie, Kaneko, Tatsuya, Kanzaki, Hiroaki, Kanayama, Kengo, Maeda, Takahiro, Saito, Tomoko, Nakagawa, Ryo, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Ogasawara, Sadahisa, Suzuki, Eiichiro, Nakamoto, Shingo, Yasui, Shin, Mikata, Rintaro, Muroyama, Ryosuke, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Mimura, Naoya, Ma, Anqi, Jin, Jian, Zen, Yoh, Otsuka, Masayuki, Kaneda, Atsushi, Iwama, Atsushi, Kato, Naoya
Publicado 2021

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment

por Mukai, Shohei, Kanzaki, Hiroaki, Ogasawara, Sadahisa, Ishino, Takamasa, Ogawa, Keita, Nakagawa, Miyuki, Fujiwara, Kisako, Unozawa, Hidemi, Iwanaga, Terunao, Sakuma, Takafumi, Fujita, Naoto, Koroki, Keisuke, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Suzuki, Eiichiro, Ooka, Yoshihiko, Muroyama, Ryosuke, Nakamoto, Shingo, Tawada, Akinobu, Chiba, Tetsuhiro, Arai, Makoto, Kato, Jun, Shiina, Manayu, Ota, Masayuki, Ikeda, Jun‐ichiro, Takiguchi, Yuichi, Ohtsuka, Masayuki, Kato, Naoya
Publicado 2021

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience

por Ogawa, Keita, Kanzaki, Hiroaki, Chiba, Tetsuhiro, Ao, Junjie, Qiang, Na, Ma, Yaojia, Zhang, Jiaqi, Yumita, Sae, Ishino, Takamasa, Unozawa, Hidemi, Kan, Motoyasu, Iwanaga, Terunao, Nakagawa, Miyuki, Fujiwara, Kisako, Fujita, Naoto, Sakuma, Takafumi, Koroki, Keisuke, Kusakabe, Yuko, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Ogasawara, Sadahisa, Suzuki, Eiichiro, Nakamoto, Shingo, Muroyama, Ryosuke, Kanda, Tatsuo, Maruyama, Hitoshi, Mimura, Naoya, Kato, Jun, Motohashi, Shinichiro, Kato, Naoya
Publicado 2022

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice

por Yumita, Sae, Ogasawara, Sadahisa, Nakagawa, Miyuki, Maruta, Susumu, Okubo, Tomomi, Itokawa, Norio, Iino, Yotaro, Obu, Masamichi, Haga, Yuki, Seki, Atsuyoshi, Kogure, Tadayoshi, Ishino, Takamasa, Ogawa, Keita, Fujiwara, Kisako, Iwanaga, Terunao, Fujita, Naoto, Sakuma, Takafumi, Kojima, Ryuta, Kanzaki, Hiroaki, Koroki, Keisuke, Inoue, Masanori, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Saito, Tomoko, Kondo, Takayuki, Nakagawa, Ryo, Nakamoto, Shingo, Muroyama, Ryosuke, Chiba, Tetsuhiro, Itobayashi, Ei, Atsukawa, Masanori, Koma, Yoshihiro, Azemoto, Ryosaku, Ito, Kenji, Mizumoto, Hideaki, Kato, Jun, Kato, Naoya
Publicado 2023